Area of research
Pediatrics, Perinatology and Child Health · Public Health, Environmental and Occupational Health
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Acute Lymphoblastic Leukemia research, Neuroblastoma Research and Treatments, and Family Support in Illness.
Risk Factors for Valvulopathy Among Childhood Cancer Survivors
Incidence patterns and temporal trends of childhood cancer in Germany, 1980–2019: Forty years of childhood cancer registration in Germany
Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
VersKiK: Study protocol of an observational registry-based study on the current state of follow-up care and adherence to follow-up guidelines after cancer in childhood or adolescence
Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors
Disclosing a history of childhood cancer to romantic partners
The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <scp>CNS</scp> and <scp>head‐and‐neck</scp> cancer patients: A report from the <scp>PanCareLIFE</scp> consortium
Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults
Die Kohorte der 41.000 Langzeitüberlebenden des Deutschen Kinderkrebsregisters
Psychosexual Development and Sexual Functioning in Young Adult Survivors of Childhood Cancer
Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study
Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
Identification of Genetic Predispositions Related to Ionizing Radiation in Primary Human Skin Fibroblasts From Survivors of Childhood and Second Primary Cancer as Well as Cancer-Free Controls: Protocol for the Nested Case-Control Study KiKme
Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors
Impact of era of diagnosis on cause‐specific late mortality among 77 423 five‐year European survivors of childhood and adolescent cancer: The <scp>PanCareSurFup</scp> consortium
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
Mental health and health‐related quality of life in preschool‐aged childhood cancer survivors. Results of the prospective cohort study ikidS‐OEVA
Managing a Pan-European Consortium on Late Effects among Long-Term Survivors of Childhood and Adolescent Cancer—The PanCareLIFE Project
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study
Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study
Possible modification of <i>BRSK1</i> on the risk of alkylating chemotherapy-related reduced ovarian function
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study
Early deaths from childhood cancer in Germany 1980-2016
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset